Timeline website preview
growth mobility Zurich, CH 2 sources
Own this company? Claim the page to unlock editing and verified-owner badge.

Not applicable as 'Timeline' refers to a Google Maps feature for tracking user location history, not a standalone startup company.

Classification

Zurich CH growth mobility other b2c mobile Health ManagementData InsightsPersonal HealthWellnessAnalytics

Profile

Founded
2020
Headcount
50-200
Revenue range
unknown

Funding

Funding details not yet available.

Business model
💡 Value Proposition

Timeline automatically saves and displays your travel history and visits on a map, allowing you to revisit your routes.

👥 Customer Segments

Google Maps users with signed-in Google Accounts on Android devices.

💰 Revenue Model

direct-to-consumer-sales

📡 Channels

In-app feature within the Google Maps application for Android users.

🤝 Key Partnerships

Medical professionals, doctors, dermatologists for product endorsement and clinical validation.

⚖️ Cost Structure

R&D for clinical studies, manufacturing, marketing, and logistics.

🏗️ Key Resources

Google Maps infrastructure, GPS tracking data, and user's signed-in Google Account.

⚙️ Key Activities

Automatically recording and saving location data, visits, and routes across signed-in devices.

💬 Customer Relationships

Automated tracking and self-managed settings within the Google Account.

Strategic analysis
🏁 Competitive landscape

Competes in the longevity and mitochondrial health supplement space; differentiates through proprietary Urolithin A technology and clinical proof rather than generic supplements.

🎯 Market pains

Recalling specific travel details and historical locations of visits.

💎 Improvement suggestions
  • Diversify price-point - Introduce a lower-dose, lower-price product to capture cost-sensitive consumers while preserving the premium-pric
♟️ Strategic implications

Deep-dive into customer-acquisition cost (CAC) vs. lifetime-value (LTV) using your internal analytics? · A scenario-planning of a 20 % price-reduction vs. a 30 % discount-through-licensing strategy? · Geographic-expansion (EU-consumer-regulatory pathways, Asia-Pacific market-entry)?

🔗 Inter-block dynamics

Value-Proposition ↔ Customer-Segments - Scientific-proof (clinical-trial data) directly resonates with health-concious and bio-hacker segmen · Channels ↔ Customer-Relationships - DTC website + subscription-billing enables direct education and high-touch support, increasing LTV · Key-Resources (Patented Mitopure) ↔ Revenue-Streams - Exclusivity crea

🛡️ Credibility notes

Scientific-Support: The product’s active ingredient (Urolithin A) is backed by a registered clinical trial (NCT04783207) and multiple peer-r · Pricing-Transparency: The website clearly displays price-break-down for single-purchase vs. subscription, enabling customers to compute per- · Strategic-Partner: The partnership with Swiss-based Amazentis (o

Team

Team details not yet available.

Investors

No investors recorded yet.

Sources & references

Web verified · 2 sources
Enriched 18 Jun 2026